Selected research
Market Structure
Global Edoxaban Tosilate Tablets and Generic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Edoxaban Tosilate Tablets and Generic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Edoxaban Tosilate Tablets and Generic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Edoxaban Tosilate Tablets and Generic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Edoxaban Tosilate Tablets and Generic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Edoxaban Tosilate Tablets and Generic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Edoxaban Tosilate Tablets and Generic Drugs include Daiichi Sankyo, Lunan Pharmaceutical Group, Menarini Group and Simcere Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Edoxaban Tosilate Tablets and Generic Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Edoxaban Tosilate Tablets and Generic Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Edoxaban Tosilate Tablets and Generic Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Edoxaban Tosilate Tablets and Generic Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Edoxaban Tosilate Tablets and Generic Drugs Segment by Company
Daiichi Sankyo
Lunan Pharmaceutical Group
Menarini Group
Simcere Pharmaceutical
Edoxaban Tosilate Tablets and Generic Drugs Segment by Type
30 mg
60 mg
Other
Edoxaban Tosilate Tablets and Generic Drugs Segment by Application
Hospital
Clinic
Other
Edoxaban Tosilate Tablets and Generic Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Edoxaban Tosilate Tablets and Generic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Edoxaban Tosilate Tablets and Generic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Edoxaban Tosilate Tablets and Generic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Edoxaban Tosilate Tablets and Generic Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Edoxaban Tosilate Tablets and Generic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Edoxaban Tosilate Tablets and Generic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Edoxaban Tosilate Tablets and Generic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 30 mg
- 60 mg
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Daiichi Sankyo
- Lunan Pharmaceutical Group
- Menarini Group
- Simcere Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Edoxaban Tosilate Tablets and Generic Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Edoxaban Tosilate Tablets and Generic Drugs Market Dynamics
- 2.1 Edoxaban Tosilate Tablets and Generic Drugs Industry Trends
- 2.2 Edoxaban Tosilate Tablets and Generic Drugs Industry Drivers
- 2.3 Edoxaban Tosilate Tablets and Generic Drugs Industry Opportunities and Challenges
- 2.4 Edoxaban Tosilate Tablets and Generic Drugs Industry Restraints
3 Edoxaban Tosilate Tablets and Generic Drugs Market by Manufacturers
- 3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Edoxaban Tosilate Tablets and Generic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Edoxaban Tosilate Tablets and Generic Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Edoxaban Tosilate Tablets and Generic Drugs Manufacturers, Product Type & Application
- 3.7 Global Edoxaban Tosilate Tablets and Generic Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Edoxaban Tosilate Tablets and Generic Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Edoxaban Tosilate Tablets and Generic Drugs Tier 1, Tier 2, and Tier 3
4 Edoxaban Tosilate Tablets and Generic Drugs Market by Type
- 4.1 Edoxaban Tosilate Tablets and Generic Drugs Type Introduction
- 4.1.1 30 mg
- 4.1.2 60 mg
- 4.1.3 Other
- 4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type
- 4.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2032)
- 4.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type
- 4.3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type (2021-2032)
5 Edoxaban Tosilate Tablets and Generic Drugs Market by Application
- 5.1 Edoxaban Tosilate Tablets and Generic Drugs Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application
- 5.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2032)
- 5.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application
- 5.3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application (2021-2032)
6 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region
- 6.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2021-2032)
- 6.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2021-2026)
- 6.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Edoxaban Tosilate Tablets and Generic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region
- 7.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region
- 7.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032)
- 7.2.2 North America Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032)
- 7.3.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Daiichi Sankyo
- 8.1.1 Daiichi Sankyo Company Information
- 8.1.2 Daiichi Sankyo Business Overview
- 8.1.3 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
- 8.1.5 Daiichi Sankyo Recent Developments
- 8.2 Lunan Pharmaceutical Group
- 8.2.1 Lunan Pharmaceutical Group Company Information
- 8.2.2 Lunan Pharmaceutical Group Business Overview
- 8.2.3 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
- 8.2.5 Lunan Pharmaceutical Group Recent Developments
- 8.3 Menarini Group
- 8.3.1 Menarini Group Company Information
- 8.3.2 Menarini Group Business Overview
- 8.3.3 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
- 8.3.5 Menarini Group Recent Developments
- 8.4 Simcere Pharmaceutical
- 8.4.1 Simcere Pharmaceutical Company Information
- 8.4.2 Simcere Pharmaceutical Business Overview
- 8.4.3 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
- 8.4.5 Simcere Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Edoxaban Tosilate Tablets and Generic Drugs Value Chain Analysis
- 9.1.1 Edoxaban Tosilate Tablets and Generic Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Edoxaban Tosilate Tablets and Generic Drugs Production Mode & Process
- 9.2 Edoxaban Tosilate Tablets and Generic Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Edoxaban Tosilate Tablets and Generic Drugs Distributors
- 9.2.3 Edoxaban Tosilate Tablets and Generic Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst